Market Tracker

06/24 5:16pm ET

Endo International PLC (NASDAQ:ENDP)

14.85
Delayed Data
As of Jun 24
 -0.99 / -6.25%
Today’s Change
12.56
Today|||52-Week Range
88.54
-75.74%
Year-to-Date
Trending Tickers: UAL, MNK, ENDP, BWA
Jun 21 / TheStreet.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Jun 15 / MotleyFool.com - Paid Partner Content
Endo's (ENDP) Pain Drug Opana ER to Face FDA Panel in Fall
Jun 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close15.84
Today’s open15.12
Day’s range14.66 - 15.55
Volume10,050,357
Average volume (3 months)9,159,859
Market cap$3.4B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-0.53%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.57

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-1.33-4.57%
ICPTIntercept Pharmaceut...-11.34-7.35%
NBIXNeurocrine Bioscienc...-1.31-2.94%
ACADACADIA Pharmaceutica...-2.07-6.18%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.80
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts